Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 3932 (117th)

PASTEUR Act of 2021

referredUnited States· United States Congress· EN

Introduced

16 June 2021

Last action

2 August 2021 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Doyle, Michael F. [D-PA-14], Rep. Ferguson, A. Drew, IV [R-GA-3], Rep. Auchincloss, Jake [D-MA-4], Rep. Cárdenas, Tony [D-CA-29], Rep. Fitzpatrick, Brian K. [R-PA-1], Rep. Wenstrup, Brad R. [R-OH-2], Rep. Schrier, Kim [D-WA-8], Rep. Carter, Earl L. "Buddy" [R-GA-1], Rep. Stewart, Chris [R-UT-2], Rep. Salazar, Maria Elvira [R-FL-27], Rep. Burgess, Michael C. [R-TX-26], Rep. Casten, Sean [D-IL-6], Rep. Ross, Deborah K. [D-NC-2], Rep. DeGette, Diana [D-CO-1], Rep. Upton, Fred [R-MI-6], Marie Newman, Rep. Butterfield, G. K. [D-NC-1], Rep. Smith, Adrian [R-NE-3], Rep. Long, Billy [R-MO-7], Rep. DeSaulnier, Mark [D-CA-10], Rep. Bacon, Don [R-NE-2], Rep. Quigley, Mike [D-IL-5], Rep. Duncan, Jeff [R-SC-3], Rep. Peters, Scott H. [D-CA-50], Rep. Kelly, Mike [R-PA-16], Rep. Craig, Angie [D-MN-2], Rep. Johnson, Bill [R-OH-6], Del. Norton, Eleanor Holmes [D-DC-At Large], Rep. Levin, Andy [D-MI-9], Rep. Mrvan, Frank J. [D-IN-1], Rescom. González-Colón, Jenniffer [R-PR-At Large], Rep. Dean, Madeleine [D-PA-4], Rep. Miller-Meeks, Mariannette [R-IA-1], Rep. Panetta, Jimmy [D-CA-19], Rep. Murphy, Gregory F. [R-NC-3], Rep. Levin, Mike [D-CA-49], Rep. Schweikert, David [R-AZ-1], Rep. Lieu, Ted [D-CA-36], Rep. Amodei, Mark E. [R-NV-2], Rep. Matsui, Doris O. [D-CA-7], Sen. Mullin, Markwayne [R-OK], Rep. Delgado, Antonio [D-NY-19], Rep. Bucshon, Larry [R-IN-8], Rep. Wild, Susan [D-PA-7], Rep. Carey, Mike [R-OH-15], Rep. Garamendi, John [D-CA-8], Rep. Scott, Austin [R-GA-8], Rep. O'Halleran, Tom [D-AZ-1]

Subjects

Healthcare

Source updated

21 January 2026

Healthcare

Official sourceDownload fileView documentsShare

Summary

The Pioneering Antimicrobial Subscriptions To End Up surging Resistance Act of 2021 or the PASTEUR Act of 2021 This bill authorizes the Department of Health and Human Services (HHS) to enter into subscription contracts for critical-need antimicrobial drugs, provides $11 billion in appropriations for activities under the bill, and contains other related provisions. A manufacturer of a Food and Drug Administration-approved antimicrobial drug may apply to HHS to have the drug designated as a critical-need antimicrobial, and HHS may enter into a subscription contract for such a critical-need antimicrobial. The bill imposes certain requirements related to such contracts, including a mechanism to lower payments under the contract in certain instances to limit the manufacturer's revenue from the drug. Furthermore, HHS and the Centers for Disease Control and Prevention (CDC) shall award grants to support efforts to encourage the appropriate use of antimicrobial drugs and efforts to combat antimicrobial resistance. The CDC shall also track and assess data relating to antibacterial resistance and human antibiotic use and make such data publicly available. HHS shall also establish a Committee on Critical Need Antimicrobials. The committee shall develop a list of prioritized infections for which new antimicrobial drug development is needed, among other duties. Within six years of the bill's enactment, the Government Accountability Office shall report to Congress a study on the bill's effectiveness in developing priority antimicrobial drugs.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 16 June 2021

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  2. 16 June 2021

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Veterans' Affairs, Armed Services, the Judiciary, and Homeland Security, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  3. 16 June 2021

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 16 June 2021

    Introduced

    Introduced in House

    Source: IntroReferral

  5. 17 June 2021

    Referred

    Referred to the Subcommittee on Oversight, Management, and Accountability.

    Source: Committee

  6. 2 August 2021

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 16 June 2021

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 16 June 2021

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 16 June 2021

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 72 sponsors and actors.

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.